Skip to content

Clinical trials

Completed Carcinoma, Hepatocellular trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Completed Country / region: Switzerland Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20073
20082
20092
20101
20111
20122
20134
20154
20163
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
Swiss Cancer Institute5
Boston Scientific Corporation2
Bristol-Myers Squibb2
Eli Lilly and Company2
Insel Gruppe AG, University Hospital Bern2
Terumo Europe N.V.2
Amgen1
Blueprint Medicines Corporation1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular28
Liver Neoplasms9
Bile Duct Neoplasms2
Gallbladder Neoplasms2
Neoplasms2
Pain2
Anorexia1
Body Weight Changes1
Brain Neoplasms1
Breast Neoplasms1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.